Look for Drugs and Conditions

METHYLPHENIDATE

METHYLPHENIDATE



Indications

Narcolepsy and attention-deficit hyperactivity disorder (ADHD)


Dosage

Oral; 10-60 mg daily given in 2 or 3 divided doses.


Contra-Indications

hypersensitive to the drug, marked anxiety, tension, agitation, glaucoma, Tourette's syndrome, along with monoamine oxidase inhibitors, and also within a minimum of 14 days following discontinuation of a monoamine oxidase inhibitor.


Special Precautions

Paediatric: Safety not established in less than 6 years of age Pregnancy: category C; Use if risk to fetus outweighs benefits. Lactation: Not known if excreted in milk Elderly: May aggravate cardiac problems


Side Effects

nervousness, agitation, anxiety, insomnia, loss of appetite, nausea, vomiting, dizziness, palpitations, headache, increased heart rate, increased blood pressure, and psychosis.


Drug Interactions

Caffeine, pseudoephedrine, monoamine oxidase inhibitors (MAOIs), for example, isocarboxazid (Marplan).


Other Brands With Same Generic
Brand Name Manufactured by
ADDWIZE Sun Pharmaceutical Industries Ltd.
ADDWIZE OD Sun Pharmaceutical Industries Ltd.
Ad 5